glp-1 after bariatric surgery vs Medications for Long-Term Weight Loss Bariatric surgery rates decline as

Many people share amazing success stories about how their lives have changed for the better

If a patient on Fosamax or another bisphosphonate reports new or worsening thigh pain, this warrants communication with the prescriber

Why is this necessary if nutrition, sleep, and resistance training are optimized

Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold

Including these can support overall wellness